Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Terminated 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Lymphoma 22Breast Neoplasms 16Leukemia 13Multiple Myeloma 12Lymphoma, Large B-Cell, Diffuse 12Hodgkin Disease 11Neuroblastoma 10Lymphoma, Follicular 10Burkitt Lymphoma 10Leukemia, Myeloid, Acute 9Sarcoma 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Neutropenia 8Lymphoma, Non-Hodgkin 8Leukemia, Myelomonocytic, Acute 8Leukemia, Monocytic, Acute 8Leukemia, Megakaryoblastic, Acute 8Leukemia, Erythroblastic, Acute 8Neoplasms, Plasma Cell 6Lymphoma, Mantle-Cell 6Lymphoma, Large-Cell, Immunoblastic 6Malignant mesenchymal tumor 5Congenital Abnormalities 5Rhabdomyosarcoma 4Leukemia, Myeloid, Chronic-Phase 4Kidney Neoplasms 4Immunoglobulin Light-chain Amyloidosis 4Endometrial Neoplasms 4Central Nervous System Neoplasms 4Carcinoma, Non-Small-Cell Lung 4

Interventions

Carboplatin 17Radiotherapy 13Paclitaxel 13Cisplatin 9Vinorelbine 5Pemetrexed 5Gemcitabine 5Docetaxel 5Mastectomy, Segmental 4Gefitinib 4Bevacizumab 4Taxes 3Radiation 3Etoposide 3ceritinib 2shark cartilage extract 1pembrolizumab 1pegfilgrastim 1lorlatinib 1lazertinib 1efaproxiral 1Vindesine 1Vinblastine 1Tirapazamine 1Therapeutics 1Thalidomide 1Surgical Procedures, Operative 1Nivolumab 1Neoadjuvant Therapy 1Ipilimumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Adenocarcinoma of Lung × Filgrastim × Clear all
NCT00113386 2013-06-28

Cisplatin and Docetaxel With or Without Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Newly Diagnosed Stage III Non-Small Cell Lung Cancer

Radiation Therapy Oncology Group

Phase 3 Terminated
19 enrolled 5 charts
Thoracic

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡